LIPOFEN Drug Patent Profile
✉ Email this page to a colleague
When do Lipofen patents expire, and what generic alternatives are available?
Lipofen is a drug marketed by Cipher Pharms Inc and is included in one NDA.
The generic ingredient in LIPOFEN is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lipofen
A generic version of LIPOFEN was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
Summary for LIPOFEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 138 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,071 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LIPOFEN |
| What excipients (inactive ingredients) are in LIPOFEN? | LIPOFEN excipients list |
| DailyMed Link: | LIPOFEN at DailyMed |
Recent Clinical Trials for LIPOFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Scripps Research Institute | Phase 2 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 2 |
| Washington University School of Medicine | N/A |
Pharmacology for LIPOFEN
Anatomical Therapeutic Chemical (ATC) Classes for LIPOFEN
US Patents and Regulatory Information for LIPOFEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-001 | Jan 11, 2006 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-002 | Jan 11, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIPOFEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-001 | Jan 11, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-002 | Jan 11, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LIPOFEN
See the table below for patents covering LIPOFEN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 4380896 | ⤷ Try a Trial | |
| European Patent Office | 0801562 | COMPOSITION PHARMACEUTIQUE CONTENANT DU FENOFIBRATE ET DES GLYCERIDES POLYGLYCOLYSES (PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE AND POLYGLYCOLIZED GLYCERIDES) | ⤷ Try a Trial |
| Spain | 2200048 | ⤷ Try a Trial | |
| Japan | 4322313 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
